Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 1

Status

Completed 2Terminated 1

Sponsor Class

OTHER 49NIH 12NETWORK 3

Study Type

Interventional 3

Sponsor

Cancer Type

Plasma cell 3

Conditions

Lymphoma 12Leukemia 12Neuroblastoma 8Multiple Myeloma 6Myelodysplastic Syndromes 5Central Nervous System Neoplasms 5Brain Neoplasms 5Lymphoma, Follicular 4Leukemia, Myeloid, Acute 4Leukemia, Lymphocytic, Chronic, B-Cell 4Hodgkin Disease 4Teratoma 3Neoplasms, Plasma Cell 3Lymphoma, Large B-Cell, Diffuse 3Leukemia, Myelomonocytic, Chronic 3Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3Leukemia, Monocytic, Acute 3Immunoglobulin Light-chain Amyloidosis 3Congenital Abnormalities 3Burkitt Lymphoma 3Waldenstrom Macroglobulinemia 2Recurrence 2Preleukemia 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Precancerous Conditions 2Ovarian Neoplasms 2Neoplasms by Histologic Type 2Neoplasms 2Myeloproliferative Disorders 2Lymphoproliferative Disorders 2

Interventions

Melphalan 5Dexamethasone 5Prednisone 4Peripheral Blood Stem Cell Transplantation 3Doxorubicin 3Vincristine 2Thalidomide 2Lenalidomide 2Filgrastim 2Cyclophosphamide 2valspodar 1sargramostim 1fludarabine phosphate 1Vancomycin 1Tazobactam 1Reverse Transcriptase Polymerase Chain Reaction 1Radiotherapy 1Platelet Aggregation 1Piperacillin, Tazobactam Drug Combination 1Piperacillin 1Moxifloxacin 1Morphine 1Methotrexate 1Interferon-alpha 1In Situ Hybridization, Fluorescence 1Immunoenzyme Techniques 1Gene Expression Profiling 1Fenretinide 1Etoposide 1Dextromethorphan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
NETWORK × Neoplasms, Plasma Cell × Peripheral Blood Stem Cell Transplantation × Clear all
NCT00003353 2023-06-22

High-Dose Melphalan Plus Peripheral Stem Cell Transplantation in Treating Patients With Primary Systemic Amyloidosis

Eastern Cooperative Oncology Group

Phase 2 Completed
Plasma cell

Immunoglobulin Light-chain Amyloidosis, Multiple Myeloma, Neoplasms, Plasma Cell

NCT00014508 2023-06-22

Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma

Eastern Cooperative Oncology Group

Phase 2 Completed
Plasma cell

Multiple Myeloma, Neoplasms, Plasma Cell

NCT00052884 2023-06-18

Amifostine and Melphalan in Treating Patients With Primary Systemic Amyloidosis Who Are Undergoing Peripheral Stem Cell Transplantation

Eastern Cooperative Oncology Group

Phase 1 Terminated
8 enrolled
Plasma cell

Immunoglobulin Light-chain Amyloidosis, Multiple Myeloma, Neoplasms, Plasma Cell, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡